Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRIN
2024-517595-38-00Phase 3Authorised
- Sponsor
- CHRU Tours
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Cartia in venous malformation (VM) and Superficial Phlebitis (2 arms), sponsored by CHRU Tours. Planned start Feb 2026; status: authorised.
02
Drugs
Cartia
03
Conditions
venous malformation (VM)Superficial Phlebitis
Beyond the preview
Go deeper on 2024-517595-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517595-38-00.